Pfizer Inc. Equity-NMS: PFE

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$44.06
Open :	$44.28
Today's high :	$44.3
Today's low :	$43.725
52W low :	$41.45
52W high :	$56.32
1Y :	1.57%
5Y :	23.15%
EPS(TTM): :	5.19
Shares O/S :	5.61 B
Market cap :	246.54 B

What is the share price of Pfizer Inc. today?

Pfizer Inc. (PFE) share price as of October 11, 2022, is $42.03. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Pfizer Inc.?

Yes, Indian Investors can invest in the Pfizer Inc. (PFE) Share by opening an international trading account with Angel One.

How can I purchase Pfizer Inc. shares in India?

Purchasing Pfizer Inc. (PFE) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Pfizer Inc. (PFE) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Pfizer Inc.?

Yes, you can purchase fractional shares of Pfizer Inc. (PFE) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Pfizer Inc.?

The market capitalization of Pfizer Inc. on February 6, 2023, is $235.89 B.

In which sector Pfizer Inc. belongs?

Pfizer Inc. operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in Pfizer Inc. stocks?

In order to invest in Pfizer Inc. (PFE) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.